Poxel’s Diabetes Drug Wins Japan Nod, But Competition Remains Fierce
As French biotech Poxel marks the first market approval of its oral type 2 diabetes…
02/07/2021 - 5 minutes
Diabetes
Farxiga’s Approval Fuels Chronic Kidney Disease Comeback
Until this year, there were no effective treatments for chronic kidney disease. However, the recent…
08/06/2021 - 5 minutes
Record Series A for Italian Biotech Funds Autoimmune Therapy
Italian biotech Enthera raised €28M in Series A funding to develop its drug candidate for…
28/07/2020 - 3 minutes
How Immunotherapy Could Stop and Prevent Type 1 Diabetes
People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their…
03/03/2020 - 8 minutes
Sigrid Therapeutics Prevents Type 2 Diabetes Using Silica Powder in the Gut
In Stockholm, Sweden, Sigrid Therapeutics is developing an ingestible silica powder that can treat type…
07/02/2020 - 3 minutes
Valbiotis Teams up with Nestlé to Reduce Type 2 Diabetes Risk
In a deal worth up to €67M, industry giant Nestlé Health Science will have the…
06/02/2020 - 2 minutes
Needle-Free Diabetes Care: 8 Devices that Painlessly Measure Blood Glucose
Will the daily routine of finger pricking to monitor blood glucose levels finally come to…
20/11/2019 - 5 minutes
Finnish Genetics Study Provides Clues for Treating Type 2 Diabetes
A genetic mutation common to Finnish populations has been found to protect against type 2…
04/11/2019 - 2 minutes
Update: Mixed Results for Adocia as Legal Fight with Eli Lilly Comes to a Close
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
30/09/2019 - 4 minutes
FDA Greenlights First Oral Version of Novo Nordisk’s Type 2 Diabetes Drug
The first oral drug for type 2 diabetes belonging to the class of GLP-1 agonists,…
23/09/2019 - 2 minutes
How the DIY Diabetes Community Made the Artificial Pancreas Possible
Six years ago, his three-year-old daughter was diagnosed with type 1 diabetes. This led Milos…
02/09/2019 - 8 minutes
Type 1 Diabetes Immunotherapy Shows Promise in Phase I
An immunotherapy designed by the Belgian biotech Imcyse to prevent type 1 diabetes has shown…
28/08/2019 - 3 minutes
